BioSpace News Archive

Policy

Vertex Announces European Commission Approval for KALYDECO® (ivacaftor) in Infants With Cystic Fibrosis Ages 6 Months to Less Than 12 Months With Certain Mutations in the CFTR Gene

Ivacaftor is the first and only approved medicine in Europe to treat the underlying cause of cystic fibrosis in children this young

December 10, 2019
·
5 min read
Bio NC

Chimerix Presents Updated Results from Phase 2 Clinical Trial of DSTAT in Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia at American Society of Hematology Annual Meeting

Chimerix, Inc. (Nasdaq: CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases, today announced that data relating to its dociparstat sodium (DSTAT) program, formerly known as CX-01, were presented at the 61st American Society of Hematology Annual Meeting, in Orlando, FL.

December 10, 2019
·
3 min read
Pharm Country

Bristol-Myers Squibb Presents Overall Survival and Safety Data From Pivotal CC-486 Study QUAZAR AML-001

Maintenance treatment with CC-486 resulted in a significant improvement in overall survival compared with placebo for front-line AML patients

December 10, 2019
·
9 min read
Business

Avadel Pharmaceuticals Appoints Dr. Mark McCamish to its Board of Directors

Avadel Pharmaceuticals plc, a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate for treating narcolepsy, announced the appointment of Mark McCamish, MD, Ph.D. to its board of directors, effective immediately..

December 10, 2019
·
4 min read